Will Ardelyx (ARDX) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 07/30/26
Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF's Spring Clinical MeetingsGlobeNewsWire • 05/07/26
Compared to Estimates, Ardelyx (ARDX) Q1 Earnings: A Look at Key MetricsZacks Investment Research • 04/30/26
Ardelyx Reports First Quarter 2026 Financial Results and Provides Business UpdateGlobeNewsWire • 04/30/26
Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF's Spring Clinical MeetingsGlobeNewsWire • 04/27/26
Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026GlobeNewsWire • 04/23/26
Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal OfficerGlobeNewsWire • 04/20/26
Ardelyx Announces Recipients of the 2026 Derek Forfang Patient Advocate AwardGlobeNewsWire • 03/12/26
Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-CGlobeNewsWire • 03/09/26
Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting MillionsGlobeNewsWire • 02/24/26
Ardelyx: Strong IBSRELA Growth, But Heavy Operational Spend Clouds ProfitabilitySeeking Alpha • 02/20/26